Jove
Visualize
Contact Us

Related Experiment Videos

Serum metabolite/caffeine ratios as a test for liver function.

Jadwiga Jodynis-Liebert1, Jan Flieger, Arleta Matuszewska

  • 1University of Medical Sciences, Department of Toxicology, Dojazd 30, 60-631 Pozna[S1], Poland.

Journal of Clinical Pharmacology
|March 31, 2004
PubMed
Summary

The metabolite-to-caffeine ratio effectively assesses hepatic dysfunction in cirrhosis patients. This ratio, calculated from a single blood sample, offers a practical method for evaluating liver function, especially in clinical settings.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oenological tannins mitigate rotenone-induced mitochondrial impairments and oxidative stress, with concomitant detection of urolithin A in the brain.

Biochemistry and biophysics reports·2026
Same author

Neuroprotective Effects of Cranberry Juice Treatment in a Rat Model of Parkinson's Disease.

Nutrients·2022
Same author

Pomegranate Juice Ameliorates Dopamine Release and Behavioral Deficits in a Rat Model of Parkinson's Disease.

Brain sciences·2021
Same author

Individual and Combined Treatments with Methylated Resveratrol Analogue DMU-214 and Gefitinib Inhibit Tongue Cancer Cells Growth via Apoptosis Induction and EGFR Inhibition.

International journal of molecular sciences·2021
Same author

Can Cranberry Juice Protect against Rotenone-Induced Toxicity in Rats?

Nutrients·2021
Same author

Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2020.

Clinical and experimental hepatology·2020
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Pharmacology
  • Hepatology
  • Biochemistry

Background:

  • Hepatic dysfunction significantly impacts drug metabolism.
  • Assessing liver function often requires complex and invasive methods.
  • Caffeine metabolism offers a potential biomarker for liver health.

Purpose of the Study:

  • To evaluate the utility of the metabolite-to-caffeine ratio for assessing hepatic dysfunction.
  • To compare this ratio in patients with liver cirrhosis and chronic hepatitis against healthy controls.
  • To determine the practicality of using this ratio for clinical liver function assessment.

Main Methods:

  • Administered oral caffeine (300 mg) to participants (cirrhosis, chronic hepatitis, healthy volunteers).
  • Collected blood samples at 4, 8, and 12 hours post-administration.

Related Experiment Videos

  • Quantified caffeine (CA) and its metabolites (paraxanthine - PX, theobromine - TB, theophylline - TP) using high-performance liquid chromatography.
  • Calculated pharmacokinetic parameters and metabolite/caffeine ratios (PX/CA, TB/CA, TP/CA).

    • Main Results:

    • Caffeine elimination was significantly reduced in cirrhotic patients compared to controls (lower clearance, reduced elimination coefficient, prolonged half-life).
    • Metabolite-to-caffeine ratios (PX/CA, TB/CA, TP/CA) were substantially reduced in cirrhotic patients.
    • Chronic hepatitis patients showed a less pronounced reduction in these ratios, varying by time point.
    • A strong correlation was observed between caffeine clearance and metabolite-to-caffeine ratios.

    Conclusions:

    • Metabolite-to-caffeine ratios provide a practical assessment of hepatic function in cirrhotic patients.
    • A single blood sample taken 8 or 12 hours after caffeine administration is sufficient for this assessment.
    • The test's utility is limited for patients with chronic hepatitis.